TabletsTablets
Schedule H (Prescription Required)Topical Corticosteroids & Anti-ItchCode: 1512

Apremilast Tablets 10mg

Generic Formulation:Apremilast Tablets IP 10mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹75
Brand Estimate*
₹196.15
Estimated Savings:₹121.15 (62% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Apremilast is an oral small-molecule phosphodiesterase 4 (PDE4) inhibitor on the WHO Model List of Essential Medicines. By inhibiting PDE4, it elevates intracellular cyclic adenosine monophosphate (cAMP), down-regulating pro-inflammatory cytokine expression (TNF-alpha, IL-17, IL-23) while up-regulating anti-inflammatory IL-10. Indicated for moderate-to-severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy, and active psoriatic arthritis.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1512.Report inaccuracy

Usage Guidelines

Take orally with water, with or without meals, twice daily following the initial 5-day dose-titration schedule (10 mg to 30 mg). Swallow tablets whole; do not crush or chew. Titration minimizes gastrointestinal adverse effects.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Diarrhea (usually within first 2 weeks, transient), nausea, upper respiratory tract infection, tension headache, weight loss. Rare/Severe: Severe depression and suicidal ideation, severe prolonged diarrhea, and hypersensitivity.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Monitor for new or worsening depression and suicidal thoughts. Monitor body weight regularly; evaluate unexplained significant weight loss. Reduce dose to 30 mg once daily in severe renal impairment (CrCl < 30 mL/min).

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.